National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core
Retrieved on:
Friday, September 15, 2023
Knowledge, NIDDK, Translational Genomics Research Institute, Partnership, Obesity, University, Epidemiology, Cushman, PBC, SmithGroup, Knowledge enterprise, Innovation, Research, Genomics, CBRE, Bangladesh Technical Education Board, Marketing Executives Network Group, Entrepreneurship, GateWay Community College, Risk, Arizona State University, Engineering, School, Medical school, Growth, ASU, United, Biomedical sciences, Digestive, Health, NIH, World Health Organization, Pharmaceutical industry, Management, City, Wawatay Native Communications Society
PHOENIX, Sept. 15, 2023 /PRNewswire/ -- Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.
Key Points:
- "We are thrilled to announce the expansion of National Institutes of Health - NIDDK on the Phoenix Bioscience Core at 850 PBC," said Kyle Jardine, Market Executive at Wexford Science & Technology.
- "NIH is a key research catalyst for our existing tenants, and reaffirms the PBC as Arizona's central hub for life science research and entrepreneurship.
- The new lease at 850 PBC will allow all sections of NIDDK Phoenix to be co-located in the Phoenix Bioscience Core.
- "It's an incredible win for Phoenix that more members of the NIDDK team will join our Phoenix Bioscience Core," City of Phoenix Mayor Kate Gallego said.